Nachrichten zur Alkermes PLC Aktie

Alkermes to Present at the 9th Annual SVB Leerink Global Healthcare Conference

DUBLIN , Feb. 19, 2020 /PRNewswire/ -- …

Alkermes (ALKS) Earnings and Revenues Beat Estimates in Q4

Alkermes (ALKS) beats earnings and sales estimates in the fourth quarter of 2019....…

Alkermes Reported More Revenue Than Expected. Here’s Why the Stock Is Falling.

Um den gesamten Artikel unter marketwatch.com zu lesen, klicken Sie bitte auf die Überschrift...…

Top Analyst Upgrades and Downgrades: Alkermes, Aurora Cannabis, BlackRock, Duke Energy, Nvidia, Ralph Lauren, SunPower, Veeva Systems, Yelp and More

Um den gesamten Artikel unter feedproxy.google.com zu lesen, klicken Sie bitte auf die Überschrift...…

BofA and JPM cut views on Alkermes in premarket analyst action

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alkermes PLC (ALKS) Q4 2019 Earnings Call Transcript

ALKS earnings call for the period ending December 31, 2019....…

Alkermes plc (ALKS) CEO Richard Pops on Q4 2019 Results - Earnings Call Transcript

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alkermes (ALKS) Q4 Earnings and Revenues Top Estimates

Alkermes (ALKS) delivered earnings and revenue surprises of 25.76% and 1.14%, respectively, for the quarter ended December 2019. Do the…

Alkermes Q4 top-line up 31%

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alkermes plc 2019 Q4 - Results - Earnings Call Presentation

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alkermes Plc Reports Financial Results for the Fourth Quarter and Year Ended Dec. 31, 2019 and Provides Financial Expectations for 2020

DUBLIN , Feb. 13, 2020 /PRNewswire/ --  Alkermes plc (Nasdaq:…

Alkermes (ALKS) to Report Q4 Earnings: Whats in Store-

We expect Alkermes (ALKS) to provide revenue updates on its proprietary marketed products and pipeline candidates when it releases fourth-quarter…

Heres Why Alkermes Jumped Almost 11% Today

A patent case win for its partner Biogen will give the duo time to convince multiple sclerosis patients to switch…

Alkermes (ALKS) NDA for ALKS 3831 Accepted by FDA for Review

The FDA accepts for review Alkermes (ALKS) NDA for ALKS 3831 for the treatment of schizophrenia and bipolar I disorder…

Arrowhead Pharmaceuticals, Inc.: A Better Odds-On Capital-Gain Alternative To Alkermes

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

FDA accepts Alkermes application for ALKS 3831; shares ahead 4% premarket

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alkermes Announces U.S. Food and Drug Administration Acceptance of ALKS 3831 New Drug Application for Treatment of Schizophrenia and Bipolar I Disorder

DUBLIN , Jan. 28, 2020 /PRNewswire/ --  Alkermes plc (Nasdaq:…

Alkermes (ALKS) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, Alkermes (ALKS) closed at $19.99, marking a -0.05% move from the previous day....…

Alkermes (ALKS) Gains As Market Dips: What You Should Know

Alkermes (ALKS) closed the most recent trading day at $19.52, moving +1.61% from the previous trading session....…

Alkermes: It Takes More

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

FRA:Deletion of Instruments from XETRA - 23.12.2019-001

The following instruments on XETRA do have their last trading day on 23.12.2019 Die folgenden Instrumente in XETRA haben ihren letzten…

Alkermes (ALKS) Stock Sinks As Market Gains: What You Should Know

Alkermes (ALKS) closed the most recent trading day at $20.92, moving -0.66% from the previous trading session....…

All You Need to Know About Alkermes (ALKS) Rating Upgrade to Strong Buy

Alkermes (ALKS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the companys earnings prospects.…

The Zacks Analyst Blog Highlights: Baidu, Alkermes, Commvault Systems, Veoneer and Zuora

The Zacks Analyst Blog Highlights: Baidu, Alkermes, Commvault Systems, Veoneer and Zuora...…

FDA warns Alkermes over Vivitrol misbranding

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

UPDATE 1-FDA issues warning letter to Alkermes over opioid addiction treatment ad

A print advertisement of Alkermes Plcs addiction treatment, Vivitrol, is false or misleading as it omits important risk information associated with its…

FDA told Alkermes to stop publishing Vivitrol ad

Shares of Alkermes were down 2.74% after the Food and Drug Administration published a warning letter alleging Vivitrol ads…

FDA issues warning letter to Alkermes over opioid addiction treatment ad

A print advertisement of Alkermes Plcs addiction treatment, Vivitrol, is false or misleading as it omits important risk information associated with its…

Alkermes to Present at the Evercore ISI 2nd Annual HealthCONx Conference

DUBLIN , Nov. 26, 2019 /PRNewswire/ --  …

Why Is Alkermes Stock Down 30% So Far This Year-

Alkermes (NASDAQ: ALKS) is a biotech company based out of Ireland that manufactures novel (patented) drugs in central nervous system…

Alkermes completes acquisition of Rodin Therapeutics

Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…

Alkermes Completes Acquisition of Rodin Therapeutics

DUBLIN , Nov. 25, 2019 /PRNewswire/ --  Alkermes plc  (Nasdaq:…